Gulf Breeze, Fla.
February 26, 2014
Three research grants have recently been awarded to the Andrews Research & Education Institute (AREI). Physicians at the Andrews Institute for Orthopaedics & Sports Medicine stay on the leading edge of medicine while furthering the knowledge and care of musculoskeletal injuries through participation in scientific research. Research studies are developed to address current medical needs within the community and are conducted at AREI with the goal of bettering patient outcomes and improving the quality of life for our community.
Knee injuries are one of the most commonly sustained injuries in the U. S. and can ultimately lead to secondary musculoskeletal conditions. Additionally, knee osteoarthritis is one of the most commonly treated musculoskeletal conditions treated within the U.S. Following are three grants that AREI has recently received for new relevant research studies:
$46,000 grant from Gensco Laboratories
A $46,000 grant has been awarded to AREI from Gensco Laboratories to collect data related to the use of a topical prescription gel following knee surgery. AREI researchers and physicians James R. Andrews, M.D., Charles A. Roth, M.D., and physician fellows, Darin Nye, M.D., Richard Lamour, M.D., and Filippo Chillemi, M.D., will study the product’s ability to reduce post-surgical pain and the amount of narcotics used for post-surgical pain management.
$40,000 grant from OrthoCor Medical
OrthoCor awards a $40,000 grant to AREI to investigate pulsed electromagnetic field (PEMF) therapy for the treatment of knee osteoarthritis. Pulsed electromagnetic field (PEMF) therapy has been used for bone growth stimulation and wound healing for some time. The Active Knee System is an FDA-approved Class III medical device that will be examined in an outcomes study conducted at the Andrews Institute by AREI researchers and Andrews Institute physicians , G. Daxton Steele, M.D., Joshua G. Hackel, M.D., and Brett R. Smith, M.D. The primary goal is to collect data related to the device’s efficacy and ability to reduce pain for patients suffering from osteoarthritis of the knee.
$250,000 grant from EmCyte Corporation
EmCyte awards AREI a $250,000 grant to investigate the use of autologous products to treat symptomatic knee osteoarthritis in retired professional athletes. Autologous refers to cells and tissues that are obtained and replanted back into the same individual. For the study, AREI researchers and Andrews Institute physicians James R. Andrews, M.D., Joshua G. Hackel, M.D., Adam W. Anz, M.D., and physician fellow Richard Lamour, M.D., will study the efficacy of bone marrow aspirate concentrate compared with platelet rich plasma in treating symptomatic knee osteoarthritis. The current standard of care is to take cells from the patient’s bone marrow or platelet rich plasma and re-introduced them back into the patient’s symptomatic knee. The comparative study hopes to provide more scientific evidence into which treatment affords the better patient outcome.
The Andrews Institute for Orthopaedics & Sports Medicine established the Andrews Research & Education Institute to advance the science of orthopaedic care and sports medicine. For more information about AREI, go online to TheAndrewsInstitute.com/AREI or call 850.916.8591.